Study to Assess Change in Quality of Life of Risankizumab Treatment in Adult Participants With Moderate-to-Severe Plaque Psoriasis

NCT07039110 · clinicaltrials.gov ↗
RECRUITING
Status
700
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

AbbVie